Trial Outcomes & Findings for Evaluation of On-eye Optical Performances of the RMY-100 Lens (NCT NCT03670277)

NCT ID: NCT03670277

Last Updated: 2025-04-25

Results Overview

Spherical aberration (Z4, 0) for a 5-mm pupil was measured by an aberrometer (COAS by AMO) with a distant viewing target at 4 m at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

28 participants

Primary outcome timeframe

Up to Post Lens Fitting Evaluation

Results posted on

2025-04-25

Participant Flow

A total of 28 subjects were enrolled into this study at 1 clinical site. Of those enrolled, 20 subjects in the test arm were dispensed a study lens while, 8 subjects in the control arm were not dispensed, all 28 subjects who were enrolled have completed the study.

Participant milestones

Participant milestones
Measure
Test
Subjects were fit with the Test lens at Visit 2 of the study
Control
Existing Orthokeratology patients who have \>=5 mm pupil size at Visit 1 Baseline.
Overall Study
STARTED
20
8
Overall Study
COMPLETED
20
8
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of On-eye Optical Performances of the RMY-100 Lens

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Test
n=20 Participants
Subjects were fit with the Test lens at Visit 2 of the study
Control
n=8 Participants
Existing Orthokeratology patients who have \>=5 mm pupil size at Visit 1 Baseline.
Total
n=28 Participants
Total of all reporting groups
Age, Continuous
17.9 years
STANDARD_DEVIATION 3.82 • n=5 Participants
16.8 years
STANDARD_DEVIATION 4.62 • n=7 Participants
17.6 years
STANDARD_DEVIATION 4.01 • n=5 Participants
Sex: Female, Male
Female
14 Participants
n=5 Participants
6 Participants
n=7 Participants
20 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
2 Participants
n=7 Participants
8 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
6 participants
n=5 Participants
7 participants
n=7 Participants
13 participants
n=5 Participants
Race/Ethnicity, Customized
White
10 participants
n=5 Participants
0 participants
n=7 Participants
10 participants
n=5 Participants
Race/Ethnicity, Customized
Other
4 participants
n=5 Participants
1 participants
n=7 Participants
5 participants
n=5 Participants
Region of Enrollment
Canada
20 participants
n=5 Participants
8 participants
n=7 Participants
28 participants
n=5 Participants

PRIMARY outcome

Timeframe: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

Spherical aberration (Z4, 0) for a 5-mm pupil was measured by an aberrometer (COAS by AMO) with a distant viewing target at 4 m at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Outcome measures

Outcome measures
Measure
Test
n=17 Eyes
Subjects were fit with the Test lens at Visit 2 of the study
Control
n=7 Eyes
Existing Orthokeratology patients at Visit 1 Baseline
Distance Spherical Aberration (Z4, 0)
0.350 micron
Standard Deviation 0.066
0.364 micron
Standard Deviation 0.212

PRIMARY outcome

Timeframe: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

Spherical aberration (Z4, 0) for a 5 mm pupil was measured by an aberrometer (COAS by AMO) with a near view target at 25 cm. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Outcome measures

Outcome measures
Measure
Test
n=17 Eyes
Subjects were fit with the Test lens at Visit 2 of the study
Control
n=7 Eyes
Existing Orthokeratology patients at Visit 1 Baseline
Near Spherical Aberration (Z4, 0)
0.300 micron
Standard Deviation 0.061
0.272 micron
Standard Deviation 0.144

SECONDARY outcome

Timeframe: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

Distance off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with distant viewing targets at 4 m and ±10°, ±20°, and ±30° off axis. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Outcome measures

Outcome measures
Measure
Test
n=20 Eyes
Subjects were fit with the Test lens at Visit 2 of the study
Control
n=8 Eyes
Existing Orthokeratology patients at Visit 1 Baseline
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
-30
0.3502 Diopter
Standard Deviation 3.79171
-3.0756 Diopter
Standard Deviation 1.66232
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
-20
-1.1344 Diopter
Standard Deviation 1.39215
-2.4579 Diopter
Standard Deviation 1.91260
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
-10
-0.3786 Diopter
Standard Deviation 0.94009
-0.4444 Diopter
Standard Deviation 0.53691
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
+10
-1.4402 Diopter
Standard Deviation 1.22240
-1.7429 Diopter
Standard Deviation 1.16422
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
+20
-1.9654 Diopter
Standard Deviation 1.22837
-4.4656 Diopter
Standard Deviation 2.07377
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
+30
-0.1098 Diopter
Standard Deviation 3.76589
-2.5638 Diopter
Standard Deviation 2.61755

SECONDARY outcome

Timeframe: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

Near off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with near viewing targets at 25 cm and ±30° off-axis. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Outcome measures

Outcome measures
Measure
Test
n=20 Eyes
Subjects were fit with the Test lens at Visit 2 of the study
Control
n=8 Eyes
Existing Orthokeratology patients at Visit 1 Baseline
Near Off-axis Refraction at ±30° Retinal Eccentricities.
-30
-2.3463 Diopter
Standard Deviation 3.13560
-5.3558 Diopter
Standard Deviation 2.49516
Near Off-axis Refraction at ±30° Retinal Eccentricities.
+30
-3.6046 Diopter
Standard Deviation 3.37323
-4.9883 Diopter
Standard Deviation 3.77839

Adverse Events

Test

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist

Johnson & Johnson Vision Care

Phone: 1-800-843-2020

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60